Mr.Praveen Kumar
top of page

Mr Praveen Kumar is an experienced Consultant Ophthalmologist and Cataract Surgeon in Reading and Windsor. Specialist care for cataracts, retina, AMD and laser eye conditions.

Intermediate Age-Related Macular Degeneration (AMD): Symptoms, Diagnosis, Monitoring & Treatment

Intermediate age-related macular degeneration (AMD) is a common eye condition that affects the macula, the small central area of the retina responsible for sharp, detailed vision. Intermediate AMD is an important stage of age-related macular degeneration because, although central vision may still be relatively good, there is an increased risk of progression to advanced AMD and significant sight loss.

Understanding intermediate AMD, recognising changes in vision and attending regular eye examinations can help patients protect their remaining vision and make informed decisions about their eye health.

What is intermediate AMD?

AMD develops when ageing changes affect the macula. In the early stages, AMD may cause few or no noticeable symptoms. As the condition progresses to intermediate AMD, changes within the retina become more pronounced.

Intermediate AMD is commonly associated with medium-sized or large drusen, which are deposits that develop beneath the retina. Patients may also develop areas of pigmentary change within the macula.

Intermediate AMD does not necessarily mean that severe sight loss is inevitable. Many people with intermediate AMD maintain useful vision for many years, particularly when the condition is identified early and monitored appropriately. However, intermediate AMD requires careful follow-up because it can progress to advanced AMD, including geographic atrophy (dry AMD) or neovascular (wet) AMD.

 

Under the RCOphth/NICE classification, intermediate AMD generally corresponds to retinal findings associated with a medium or high risk of progression, including:

  • Large drusen ≥125 micrometres (µm) in diameter.

  • Reticular pseudodrusen, also called subretinal drusenoid deposits.

  • Medium drusen (63 to <125 µm) with pigmentary abnormalities.

  • Large drusen ≥125 µm with pigmentary abnormalities.

  • Reticular pseudodrusen with pigmentary abnormalities.

  • Certain vitelliform lesions without significant visual loss (best-corrected visual acuity better than 6/18).

  • Atrophy smaller than 175 µm that does not involve the fovea.

What is indeterminate AMD?

Retinal pigment epithelial (RPE) degeneration and dysfunction (presence of degenerative AMD changes with subretinal or intraretinal fluid in the absence of detectable neovascularisation).

Serous pigment epithelial detachment (PED) without neovascularisation

Intermediate and Indeterminate AMD are different and denotes various stages of progression of Dry AMD

Symptoms of Intermediate AMD
Some people with intermediate AMD continue to read, drive and carry out everyday activities without major difficulty. Others notice gradual changes in their central vision.
Possible symptoms include:

  • Blurred or less sharp central vision

  • Difficulty reading small print

  • Needing brighter light for reading or close work

  • Colours appearing less vivid

  • Difficulty recognising faces

  • Straight lines appearing distorted or wavy

  • A blurred or missing area in the centre of vision

  • Increasing difficulty adapting to changes in lighting

Importantly, AMD can affect each eye differently. This means that changes in one eye may sometimes be difficult to notice because the other eye compensates.
Any new distortion, sudden reduction in vision, flashing lights, a sudden increase in floaters or a new central blind spot should be assessed promptly by an eye-care professional.

intermediate AMD READING.png
intermediate AMD distance.png
Intermediate_AMD-1_edited_edited.jpg

How is Intermediate AMD Diagnosed?

A comprehensive retinal assessment is important when intermediate AMD is suspected or already diagnosed. An ophthalmologist may perform a detailed examination of the macula and use advanced retinal imaging.

Optical coherence tomography (OCT) is particularly valuable in AMD care. OCT provides detailed cross-sectional images of the retina and can help identify changes that may not be visible during a routine eye examination.

Depending on the clinical situation, other investigations may include retinal photography, fundus autofluorescence or OCT angiography (OCTA).

Regular imaging allows an ophthalmologist to compare retinal changes over time and identify signs that AMD may be progressing.

Importance of monitoring Intermediate AMD

Monitoring is a key part of managing intermediate AMD. Mr.Kumar will recommend an appropriate review schedule based on the appearance of your retina, your symptoms and your individual risk factors.

Patients should also remain alert to changes in their vision at home. Amsler grid monitoring can be useful for detecting new distortion or changes in the central visual field. If a previously straight line suddenly appears bent or an area appears missing, patients should seek prompt ophthalmic assessment.

Regular monitoring is particularly important because wet AMD can sometimes develop relatively quickly. Early diagnosis and treatment of wet AMD can make an important difference to visual outcomes.

intemediate faf_edited.jpg
amsler grid_edited.jpg

Lifestyle and Eye Health in Intermediate AMD

Although AMD is strongly associated with ageing and genetic factors, maintaining overall health is an important part of retinal care.

Patients with intermediate AMD should consider:

  • Not smoking and avoiding exposure to tobacco smoke

  • Maintaining a healthy, balanced diet rich in vegetables and other nutrient-dense foods

  • Managing blood pressure, cholesterol and cardiovascular risk factors with their GP

  • Exercising regularly, where appropriate

  • Protecting the eyes from excessive sunlight with suitable UV protection

  • Attending scheduled retinal examinations

  • Reporting new or sudden visual symptoms promptly

Your ophthalmologist can provide individualised advice based on your retinal findings and general health.

Are Nutritional Supplements Recommended for Intermediate AMD?
Specific vitamin and mineral supplements may be recommended for some patients with intermediate AMD. Evidence from major clinical studies, including the AREDS and AREDS2 research, has helped establish when particular formulations may be beneficial in reducing the risk of progression to advanced AMD.
However, AMD supplements are not suitable for everyone, and standard multivitamins should not automatically be considered an AMD treatment. The appropriate formulation depends on the patient's diagnosis, retinal findings and medical history.
It is therefore advisable to discuss AREDS2 supplements for intermediate AMD with an ophthalmologist before starting them.

Expert Care for Intermediate AMD in Reading, Windsor and Berkshire
Intermediate AMD benefits from careful, personalised management rather than a one-size-fits-all approach. Patients often want to understand not only what their retinal scan shows, but also what it means for their future vision and how frequently they should be monitored.
Mr Praveen Kumar brings 35 years of experience in ophthalmology, including 18 years of dedicated experience in AMD and retinal care. He currently serves as Lead Consultant for AMD services in Windsor and also covers Reading, Berkshire, providing specialist assessment and management for patients with age-related macular degeneration.
His extensive experience in AMD allows patients to receive informed advice about retinal imaging, monitoring, risk of progression and appropriate treatment pathways. For patients diagnosed with intermediate AMD, specialist assessment can provide reassurance while ensuring that any important changes are identified as early as possible.

PK1_edited_edited.jpg

Living Well With Intermediate AMD
A diagnosis of intermediate AMD does not mean that significant sight loss is inevitable. With appropriate monitoring, healthy lifestyle choices, awareness of warning symptoms and access to specialist retinal care, patients can take an active role in protecting their vision.
If you have been diagnosed with intermediate age-related macular degeneration, have noticed changes in your central vision, or have been told that you have significant drusen or other macular changes, a specialist AMD assessment can help clarify your diagnosis and individual risk.
For patients across Reading, Windsor and Berkshire, Mr Praveen Kumar’s combination of 35 years of ophthalmology experience and 18 years of AMD expertise provides an experienced approach to the assessment and ongoing management of intermediate AMD.

Summary on types of clinically significant AMD

  • Intermediate AMD:Generally corresponds to early AMD with medium/high risk of progression, such as large drusen, reticular pseudodrusen and associated pigmentary abnormalities.

  • Late AMD (indeterminate): Late-stage AMD changes with subretinal/intraretinal fluid but no detectable neovascularisation, or serous PED without neovascularisation.

  • Late AMD (wet active):Neovascular AMD with demonstrable neovascularisation and activity. (WET AMD)

  • Late AMD (dry):Geographic atrophy without neovascular AMD.

  • The RCOphth/NICE classification therefore makes clear that “intermediate AMD” and “late AMD (indeterminate)” describe very different clinical situations.

Symptoms of Intermediate AMD

Some people with intermediate AMD continue to read, drive and carry out everyday activities without major difficulty. Others notice gradual changes in their central vision.

Possible symptoms include:

  • Blurred or less sharp central vision

  • Difficulty reading small print

  • Needing brighter light for reading or close work

  • Colours appearing less vivid

  • Difficulty recognising faces

  • Straight lines appearing distorted or wavy

  • A blurred or missing area in the centre of vision

  • Increasing difficulty adapting to changes in lighting

Importantly, AMD can affect each eye differently. This means that changes in one eye may sometimes be difficult to notice because the other eye compensates.

Any new distortion, sudden reduction in vision, flashing lights, a sudden increase in floaters or a new central blind spot should be assessed promptly by an eye-care professional.

bottom of page